Eurocastle Releases First Quarter 2017 Financial Results,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
100
Eurocastle Releases First Quarter 2017 Financial Results, Announces Supplemental Dividend of €0.14 per share and Annual General Meeting on 21 June 2017

Guernsey, 18 May 2017 - Eurocastle Investment Limited (Euronext Amsterdam: ECT) today has released its financial results for the first quarter ended 31 March 2017. 

  • Normalised FFO [1] of €26.0 million, or €0.43 per share [2] , for the first quarter of 2017 including one-off impacts from sales and the remaining realisations from the Legacy Business.  
  • Adjusted Net Asset Value [3] of €548.9 million, or €9.13 per share2, after the declaration of the regular quarterly dividend of €0.15 per share2.  
  • First Quarter 2017 Dividend
    • €9.0 million, or €0.15 per share2, of regular quarterly dividend declared in March 2017 and to be paid on 31 May 2017.
    • In addition, and in line with the new distribution policy announced in March 2017, the Board of Directors has declared a supplemental dividend for the period of €8.4 million, or €0.14 per share2, also payable on 31 May 2017 to shareholders of record at close of business on 23 May 2017, with an ex-dividend date of 22 May 2017 [4] .
    • In aggregate, this has resulted in a total dividend of €17.4 million, or €0.29 per share, for the first quarter of 2017.
    Q1 2017   Q4 2016  
    € million € per share2   € million € per share2  
Normalised FFO1   26.0 0.43   12.5 0.21  
Dividends [5]   17.4 0.29   9.0 0.15  
Adjusted NAV3   548.9 9.13   550.6 9.16  
  • Annual General Meeting
    • The Company further announces that it will hold its Annual General Meeting on Wednesday, 21 June 2017, at the Company's registered office at 2:00 pm London time (3:00 pm CET).

BUSINESS HIGHLIGHTS

  • Investment Realisations - During the first quarter of 2017, Eurocastle sold its interest in the units of Real Estate Fund Investment III. The sale resulted in total proceeds of €20.9 million, or €0.35 per share, realising a total lifetime gross profit of €18.0 million, an IRR of 137% and 2.7x multiple on equity invested. The sale was achieved two years ahead of business plan. In addition, the Company realised a gross profit of €7.2 million from the resolution of a debt claim it had acquired in the period.  
  • doBank - In March 2017, the board of doBank approved a dividend of €52.3 million (of which Eurocastle's share is €26.2 million) for the year ended 31 December 2016 which is expected to be paid by the end of May 2017. For the first quarter of 2017 the doBank Group reported EBITDA of €9.9 million; 44% higher than the same period last year on a like-for-like basis [6] ; a period that is typically the lowest in the year given the seasonality of NPL collections.  
  • Legacy Business [7] - In the first quarter of 2017, the Group received €2.4 million of cash flow upon completion of German real estate sales that were previously under binding contracts. In addition, the Company received €0.6 million from the resolution of a Legacy debt investment. The Company intends to unwind its remaining Legacy levered portfolio (CDO V) during the remainder of 2017.

                             

  • BUSINESS HIGHLIGHTS SUBSEQUENT TO 31 MARCH 2017
  • Romeo NPL Portfolio Financing - on the 3rd of May 2017, the Company announced the successful completion of a €75 million financing on the secured portion of its Romeo NPL portfolio. As a result, Eurocastle received approximately €36 million or 50% of the net proceeds after costs and reserves. At the same time, Eurocastle received over €18 million of previously undistributed cash from the portfolio, resulting in total proceeds to the Company of approximately €54 million.  
  • Italian Real Estate Fund Investment V - In April 2017 the Company closed on its previously committed investment in Real Estate Fund V, deploying an additional €4.0 million. This brings the total equity deployed to date to €4.4 million with an expected further €1.4 million to be deployed predominantly over the next 12 months.  
  • Italian Real Estate Fund Investment I Realisation - In May 2017, the Company received a distribution of €4.8 million primarily from sales made by the fund in 2016.

NORMALISED FFO

Normalised FFO is a non-IFRS financial measure that, with respect to the Company's Italian Investments [8] , recognises i) income on an expected yield basis updated periodically, allowing Eurocastle to report the run rate earnings from these investments in line with their expected annualised returns and ii) any additional gains or losses not previously recognised through NFFO at the point investments are fully realised. On Eurocastle's Legacy Business, the measure excludes realised gains and losses, sales related costs (including realised swap losses), impairment losses, foreign exchange movements and any movements on portfolios with a negative NAV other than sales or asset management fees realised.

Eurocastle believes that focusing on the Normalised FFO of the Company's Italian Investments will enhance investors' understanding of current and future earnings given annualised returns achieved and the average net invested capital [9] over the relevant period.

Segmental Normalised FFO for the Three Months Ended 31 March 2017 Average Net Invested Capital 3     Italian Investments 2 Legacy Total
  € Thousands Yield   € Thousands € Thousands € Thousands
doBank Investment 246,033 15% 8,975 - 8,975
Italian NPLs [10] 24,432 15% 939 - 939
Real Estate Fund Investments 46,002 130% 15,021 - 15,021
Other [11] n/a n/a 7,247 - 7,247
Italian Investments NFFO before expenses 316,467 41% 32,182 - 32,182
Legacy Portfolios NFFO before expenses - 2,826 2,826
Manager Base & Incentive Fees (7,728) - (7,728)
Other operating expenses (1,082) (219) (1,301)
Normalised FFO 23,372 2,607 25,979
Per Share 6 0.39 0.04 0.43
Income Statement for the Three Months Ended 31 March 2017 Italian Investments € Thousands Legacy € Thousands Total € Thousands
Portfolio Returns      
  Fair value movements on joint ventures:      
  doBank Group [12] (93) - (93)
  Romeo NPLs 1 2,359 - 2,359
  Share of post-tax profit from joint ventures:
  NPLs - Pool 6 8 - 8
  Real Estate Fund Investment II 495 - 495
  Fair value movements on associates:
  Real Estate Fund Investment III 1,444 - 1,444
  Real Estate Fund Investment IV 1,414 - 1,414
Share of post-tax profits from associates:
  NPLs - Pools 7-18 340 - 340
Fair value movements on other investments:
NPLs/PL - Pools 1-5 105 - 105
Real Estate Fund Investment I 155 - 155
  Other Income
  Other income - 2,351 2,351
  Gains on foreign currency translations and swaps 7,255 - 7,255
Total operating income 13,482 2,351 15,833
 
Operating expenses
  Interest expense 42 - 42
  Other operating expenses
  Transaction costs 134 - 134
  Manager Base Incentive fees 7,728 - 7,728
   Remaining operating expenses 892 - 892
Total operating expenses 8,796 - 8,796
 
Net operating profit before taxation 4,686 2,351 7,037
 
  Total tax expense 14 - 14
Net profit after taxation from continuing operations 4,672 2,351 7,023
 
  Net Loss after taxation from discontinued operations - (153) (153)
Profit after taxation for the period 4,672 2,198 6,870
Per Share [13] 0.08 0.03 0.11
       
  Non-controlling interest 20 - 20
Net profit attributable to ordinary shareholders after taxation 4,652 2,198 6,850
Per Share 2 0.08 0.03 0.11
       
  Reversal of Loss attributed to negative NAV portfolios [14] - 226 226
Adjusted net profit 4,652 2,424 7,076
Per Share 2 0.08 0.04 0.12

Excluding losses from CDO V (the Group's remaining Legacy investment with a negative NAV) the Group generated a net profit after taxation of €7.1 million, or €0.12 per share. As at 31 March 2017, the Group had an Adjusted NAV of nil for its remaining Legacy interest (CDO V) and does not expect any further material cash flows from this investment.

Balance Sheet and Adjusted NAV Reconciliation as at 31 March 2017 Italian Investments € Thousands   Corporate € Thousands Legacy € Thousands Total € Thousands
Assets        
Cash and cash equivalents 4,958 119,302 5,082 129,342
Other assets 22 1,145 510 1,677
Available for sale securities 5,653 - - 5,653
Investments in joint ventures
  doBank Group [15] 269,953 - - 269,953
  Romeo NPLs 1 103,144 - - 103,144
  NPLs - Pool 6 1,629 - - 1,629
  Real Estate Fund Investment II 10,744 - - 10,744
  Real Estate Fund Investment V 400 - - 400
Investments in associates
  NPLs - Pools 7 - 18 23,291 - - 23,291
  Real Estate Fund Investment IV 19,028 - 2,208 21,236
Other fair value investments
  NPLs/PL - Pools 1-5 3,736 - - 3,736
  Real Estate Fund Investment I 14,434 - - 14,434
Loans and receivables held for sale - - 5,341 5,341
Derivative assets - - 1,190 1,190
Total assets 456,992 120,447 14,331 591,770
 
Liabilities
Trade and other payables 4,385 21,388 3,044 28,817
Current taxation payable 22 1,975 113 2,110
CDO bonds payable - - 54,471 54,471
Total liabilities 4,407 23,363 57,628 85,398
 
Net Asset Value 452,585 97,084 (43,297) 506,372
 
Non-controlling interest (806) - - (806)
Net Asset Value after Non-controlling interest 451,779 97,084 (43,297) 505,566
 
Negative NAV Addbacks 2 - - 43,297 43,297
Committed Investments 3 65,357 (65,357) - -
Adjusted NAV 517,136 31,727 - 548,863
Adjusted NAV (€ per Share) 4 8.60 0.53 - 9.13

ADDITIONAL INFORMATION

For additional information that management believes to be useful for investors, please refer to the latest presentation posted on the Investor Relations section of the Company's website, www.eurocastleinv.com. For consolidated investment portfolio information, please refer to the Company's most recent Financial Report, which is available on the Company's website (www.eurocastleinv.com).

EARNINGS CALL INFORMATION

Eurocastle's management will host an earnings conference call at 2:00 P.M. London time (9:00 A.M. New York time) later today. All interested parties are welcome to participate on the live call. You can access the conference call by dialling first +1- 800-215-5243 (from within the U.S.) or +1-330-863-8154 (from outside of the U.S.) ten minutes prior to the scheduled start of the call; please reference "Eurocastle First Quarter 2017 Earnings Call" or "conference ID number 21936653".

A webcast of the conference call will be available to the public on a listen-only basis at www.eurocastleinv.com. Please allow extra time prior to the call to visit the site and download the necessary software required to listen to the internet broadcast. A replay of the webcast will be available for three months following the call.

For those who are not available to listen to the live call, a replay will be available until 11:59 P.M. New York time on Thursday, 01 June 2017 by dialing +1-855-859-2056 (from within the U.S.) or +1-404- 537-3406 (from outside of the U.S.); please reference access code "21936653"

ANNUAL GENERAL MEETING

The Company will hold its Annual General Meeting on Wednesday, 21 June 2017, at the Company's registered office at 2:00 pm London time (3:00 pm CET). Notices and proxy statements will be mailed out to all holders on record as of Thursday, 18 May 2017. In addition, the Company has posted the Annual General Meeting notice on its website under Periodic Reports and Shareholder Communications in the Investor Relations Section.

ABOUT EUROCASTLE

Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and non-performing loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol "ECT". Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com .

FORWARD LOOKING STATEMENTS

This release contains statements that constitute forward-looking statements. Such forward-looking statements may relate to, among other things, future commitments to sell real estate and achievement of disposal targets, availability of investment and divestment opportunities, timing or certainty of completion of acquisitions and disposals, the operating performance of our investments and financing needs. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "may", "will", "should", "potential", "intend", "expect", "endeavour", "seek", "anticipate", "estimate", "overestimate", "underestimate", "believe", "could", "project", "predict", "project", "continue", "plan", "forecast" or other similar words or expressions. Forward-looking statements are based on certain assumptions, discuss future expectations, describe future plans and strategies, contain projections of results of operations or of financial condition or state other forward-looking information. The Group's ability to predict results or the actual effect of future plans or strategies is limited. Although the Group believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, its actual results and performance may differ materially from those set forth in the forward-looking statements. These forward-looking statements are subject to risks, uncertainties and other factors that may cause the Group's actual results in future periods to differ materially from forecasted results or stated expectations including the risks regarding Eurocastle's ability to declare dividends, amortise the Group's debts, renegotiate the Group's credit facilities, make new investments, or achieve its targets regarding asset disposals or asset performance.

[1] Normalised FFO ("NFFO") is a non-IFRS measure used to provide additional information regarding the underlying performance of the Company, as outlined on page 13 of the Q1 2017 Interim Report. 

[2] Amounts per share are calculated on the following basis for the relevant period: Q1 2017 and Q4 2016 NFFO - 60.1 million of weighted average shares. Q1 2017 and Q4 2016 dividends and Adjusted Net Asset Value ("Adjusted NAV") - 60.1 million ordinary shares in issue (net of 6.0 million shares held in treasury). 

[3] Adjusted Net Asset Value accounts for the €9.0 million, or €0.15 per share, dividend declared in March 2017 but not the €8.4 million, or €0.14 per share, supplemental dividend declared in May 2017. Adjusted Net Asset Value also excludes the Group's remaining Legacy portfolio with negative NAV (CDO V) whose debt is non-recourse to Eurocastle. 

[4] Please refer to page 15 of the Q1 2017 Interim Report for further detail with regards to the Company's distribution policy and composition of the total dividend declared for the period.

[5] Q1 2017 dividend represents both the dividend declared in March 2017 of €9.0 million, or €0.15 per share, and a supplemental dividend of €8.4 million, or €0.14 per share, declared in May 2017. 

[6] Like-for-like Q1 2016 EBITDA is pro forma for doBank, Italfondiario and their subsidiaries and adjusted to exclude the net impact of the Romeo NPL portfolio (spun-off by the Group in September 2016). 

[7] All investments owned by the Group prior to April 2013. 

[8] All investments acquired by the Group since the establishment of its new strategy in April 2013, previously labelled as "New Investments".

[9] Time weighted average of invested capital (net of any capital returned) over the relevant period.

[10] Excludes the Romeo NPL pool which is included under the doBank Investment. 

[11] Fully realised investment. 6 Normalised FFO per share based on 60.1 million weighted average ordinary shares for Q1 2017.

[12] doBank Group fair value movement includes €0.1 million movement from the 5% interest in the Romeo NPL pool acquired as part of the doBank investment and spun-off in September 2016. Conversely, the Romeo NPL pool fair value movement reflects the movement on the remaining 95% interest of the NPL pool.

[13] Earnings per share based on 60.1 million weighted average ordinary shares for the three months ended 31 March 2017.

[14] Reverses gains and losses arising from portfolios with a negative net asset value net of any cash distributions or fees received by the Company.  

[15] doBank Group value includes €5.4 million representing the 5% interest in the Romeo NPL pool acquired as part of the doBank investment and spun-off in September 2016. Conversely, the Romeo NPL pool value reflects the remaining 95% interest in the NPL pool acquired as part of the doBank investment and spun-off in September 2016. 2 Adjusts to exclude the Group's remaining Legacy portfolio with negative NAV (CDO V) whose debt is non-recourse to Eurocastle.  3 Adjusted NAV of Italian Investments includes €60 million of equity allocated against the FINO transaction (reflecting the midpoint of the expected equity requirement of €50 to €70 million) and a €5.4 million estimated remaining commitment allocated against RE Fund Investment V. 4 Adjusted NAV per share based on 60.1 million ordinary shares in issue.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Driven Tech Lands on 2026 CRN AI Innovators List

Updated Category News Views 4

New Milestone for Driven Tech in AI Innovation If there's one thing that's becoming crystal clear in the tech world, it's this: AI isn't just a flashy add-on anymore. Companies are diving deep into AI waters, transforming their business strategies from the ground up. Driven Tech, Inc., is doing just that, and their efforts haven't gone unnoticed—they’ve made it onto...

Continue Reading
Clarivate Taps Global Appetite for AI Research Tools

Updated Category News Views 8

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

Continue Reading
PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

Updated Category News Views 1

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 3

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Rznomics Advances with EU Orphan Status for RZ-001

Updated Category News Views 3

RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...

Continue Reading
Durabook R12 Tablet: A Rugged Revolution for AI Tasks

Updated Category News Views 7

Edge AI Gets a Rugged Boost with Durabook's R12 In a world teeming with tech gadgets that crumble at the first sign of a challenge, Durabook's R12 Rugged Tablet makes a solid entrance. This ain't your everyday pretty gadget. Think of it as the big, burly bodyguard of tablets, ready to box through harsh environments without dropping a pixel. What’s stirring the pot this...

Continue Reading
When Families Should Consider Life Insurance Plans

Updated Category News Views 0

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Continue Reading
Hims & Hers Faces Class Action: Investor Implications

Updated Category News Views 6

Serious Scrutiny for Hims & Hers There's trouble in paradise, folks. Hims & Hers Health, Inc. (NYSE: HIMS) just landed in hot water, and it's not the soothing kind. We're talking about allegations of privacy violations and deceptive practices that have sent ripples—or more like waves—across the investor pond. If you're holding shares, you've probably felt the jolt...

Continue Reading
UMC and AP Memory Boost Power with New AI Chips

Updated Category News Views 4

Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...

Continue Reading
AuraQuantic Leads SPARK Matrix™ in 2026 IPO Ranking

Updated Category News Views 2

Not Just Another Day in Tech When tech outfits make headlines, it's often because of a shiny new gadget or some jarring security breach. Today, it's AuraQuantic getting their well-deserved spotlight, having snagged the leader's spot in the SPARK Matrix™ for Intelligent Process Orchestration (IPO). You might be wondering what makes this accolade worth attention in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Atlassian's Recent Options Activity Surge

Updated Category News Views 163

Analyzing Atlassian's Options Activity Recently, significant activity has been noted in the options market for Atlassian (NASDAQ: TEAM), suggesting fluctuating sentiment among investors. With several key trades occurring, it is vital to understand the underlying forces driving these changes. Insights from Options Trading An examination of options history indicates that a...

Continue Reading
Oncolytics Biotech's Strategic Move to Lead Cancer Innovation

Updated Category News Views 176

Oncolytics Biotech's Strategic Move to Lead Cancer Innovation In a time where the global oncology drug market is projected to exceed an astounding $900 billion, interest in cancer-focused biotechnology companies has surged significantly. Analysts highlight the increasing demand for innovative diagnostics and advanced immunotherapies driving this growth. Yet, as these...

Continue Reading
Transformations in Admirals Group AS Leadership and Governance

Updated Category News Views 170

Changes in Leadership at Admirals Group AS Admirals Group AS recently held a significant general meeting where key changes to its management and supervisory boards were decided. Effective from a stated future date, Anton Tikhomirov and Fedor Ragin have been appointed to the supervisory board for a term of five years. This shift marks an exciting new chapter in the...

Continue Reading
Athens Stock Market Reaches New Heights with Gains

Updated Category News Views 175

Athens Stock Market Performance Overview The latest updates reveal that Greece's stock market has closed on a positive note, showcasing notable increases across various sectors. The Athens General Composite Index has gained traction, finishing higher as key market sectors, particularly Construction, Travel, and Banking, experienced substantial growth. Sectorwise...

Continue Reading
Johnson & Johnson's Tremfya Shows Promising Results for Crohn's Disease

Updated Category News Views 227

Introduction to Tremfya and Crohn's Disease Tremfya, a medication developed by Johnson & Johnson, has gained notable attention for its role in treating Crohn's disease. Recently, new results from its Phase 3 GRAVITI study have sparked interest in its potential expanded usage, showing promising outcomes for patients. Exciting Results from the GRAVITI Study The GRAVITI...

Continue Reading